F106C (p.Phe106Cys) variant of DRD3 (Dopamine receptor D3)

F106C (p.Phe106Cys) in DRD3 (Dopamine receptor D3) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.55 / 1. The record also includes structural context.

F106C (p.Phe106Cys) variant details